Edition:
United States

Access Bio Inc (950130.KQ)

950130.KQ on KOSDAQ - Korea Secs Dealers Association Quotation

4,350.00KRW
10:29pm EDT
Change (% chg)

₩-10.00 (-0.23%)
Prev Close
₩4,360.00
Open
₩4,365.00
Day's High
₩4,365.00
Day's Low
₩4,305.00
Volume
4,210
Avg. Vol
69,594
52-wk High
₩8,150.00
52-wk Low
₩3,965.00

Latest Key Developments (Source: Significant Developments)

Access Bio lowers conversion price of 2nd series convertible bonds to 4,834 won/share
Wednesday, 26 Jul 2017 11:30pm EDT 

July 27 (Reuters) - Access Bio Inc <950130.KQ> ::* Says it lowered conversion price of 2nd series convertible bonds to 4,834 won/share from 5,197 won/share, effective July 27 .  Full Article

GE, Global Good Licensing deal with Access Bio brings asymptomatic malaria rapid diagnostic tests to market
Wednesday, 12 Jul 2017 11:00am EDT 

July 12 (Reuters) - GE:GE, global good licensing deal with Access Bio brings asymptomatic malaria rapid diagnostic tests to market.Agreement includes technology to create malaria serology tests for plasmodium antibodies which can measure population's past exposure to disease​.Agreement covers diagnostic test that identifies key proteins present in malaria, as well as PLDH RDT to detect malarial parasites.  Full Article

Access Bio receives patent
Wednesday, 21 Jun 2017 04:34am EDT 

June 21 (Reuters) - Access Bio Inc <950130.KQ> ::* Says it received patent on June 21, for single-pad strip for an improved lateral flow assay and a test device using the same.* Says patent number is 10-2014-7003992.  Full Article

Access Bio receives patent
Tuesday, 16 May 2017 09:51pm EDT 

May 17 (Reuters) - Access Bio Inc <950130.KQ> ::* Says it receives patent about chromatographic assay system .* Says patent number is 201410251375.5.  Full Article

Access Bio signs contract worth 2.0 bln won
Thursday, 13 Apr 2017 09:46pm EDT 

Access Bio Inc <950130.KQ> :Says it signed a 2.0 billion won contract with PFSCM (Partnership for Supply Chain Management) to provide malaria RDT in Congo.  Full Article

Access Bio lowers conversion price of 1st series bonds to 5,535 won/share
Thursday, 2 Mar 2017 09:42pm EST 

Access Bio Inc <950130.KQ> :Says it lowered conversion price of first series bonds to 5,535 won/share from 7,906 won/share.  Full Article

Access Bio signs contract worth 1.45 bln won
Sunday, 1 Jan 2017 09:15pm EST 

Access Bio Inc <950130.KQ> : Says it signed a 1.45 billion won contract with PFSCM (Partnership for Supply Chain Management), to provide malaria RDT in Ivory Coast .Contract period is from Dec. 30 to March 16. 2017.  Full Article

Access Bio receives patent
Wednesday, 21 Dec 2016 10:01pm EST 

Access Bio Inc <950130.KQ> :Says it receives patent about single-pad strip for an improved lateral flow assay and a test device.  Full Article

Access Bio signs contract worth 4.42 bln won
Friday, 2 Dec 2016 01:01am EST 

Access Bio Inc <950130.KQ> : Says it signed contract with Bill & Melinda Gates Foundation on Nov. 30, to support R&D for project of creating a "Center for Advanced Accessible Diagnostices (CAAD)" to Catalyze Next Generation Technologies for Resource-Limited Settings . Says contract amount is 4.42 billion won .Says contract period is from Nov. 30 to April 1, 2018.  Full Article

Access Bio signs contract worth 2.89 bln won
Wednesday, 31 Aug 2016 10:54pm EDT 

Access Bio Inc <950130.KQ> : Says it signs contract with Partnership for Supply Chain Management, to supply RDT .Contract amount of 2.89 billion won.  Full Article

BRIEF-GE, Global Good Licensing deal with Access Bio brings asymptomatic malaria rapid diagnostic tests to market

* GE, global good licensing deal with Access Bio brings asymptomatic malaria rapid diagnostic tests to market